A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study of the Efficacy and the Safety and Tolerability of BMS-986278 in Participants with Pulmonary Fibrosis

Project Details

StatusFinished
Effective start/end date23/07/2030/06/23

Funding

  • Bristol-Myers Squibb Australia: A$181,953.00